KX2-361 | m-entrepreneurship.com

Product Name :
KX2-361

Search keywords :
KX2-361

drugId :
null

Target Vo:
Tyrosine-protein kinase SRC

Target Vo Short Name :
SRC

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Athenex Inc

Active Company_Name :
Guangzhou Xiangxue New Drug Development Co Ltd

Active Indication_Name:
Glioma

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Spike-RBD mAb In Vivo
Anti-Mouse CD209b Antibody (22D1) medchemexpress
TNFRSF10B Antibody (YA660): TNFRSF10B Antibody (YA660) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to TNFRSF10B (7F4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts